pantoprazole (Protonix)

04/01/2006 - "Pantoprazole (20 and 40 mg) is effective in reducing endoscopically proven GERD symptoms in children. "
04/01/2006 - "To evaluate symptom improvement in 53 children (aged 5-11 years) with endoscopically proven gastroesophageal reflux disease (GERD) treated with pantoprazole (10, 20 and 40 mg) using the GERD Assessment of Symptoms in Pediatrics Questionnaire. "
01/01/2014 - "Pantoprazole-Mg 40 mg significantly improved a broad range of esophageal and extra-esophageal GERD related symptoms including sleep disturbances, as well as well-being, in patients with daytime or night-time GERD, making it a good option for patients with GERD, especially when extra-esophageal and night-time symptoms are present."
06/01/2010 - "Pantoprazole significantly improved GERD symptom scores and was well tolerated. "
06/01/2007 - "In addition, oral pantoprazole has been shown to improve the quality of life of patients with GERD and is associated with high levels of patient satisfaction with therapy. "

12/01/2015 - "Pantoprazole was the most widely prescribed off-label INN for stress ulcer prevention (62 %). "
01/01/2012 - "Ulcer bleeders were given either 80 mg bolus of pantoprazole followed by continuous infusion of 8 mg per hour or saline infusion until endoscopy. "
07/01/2011 - "To compare the anti-ulcer activity of buffered pantoprazole tablet against plain pantoprazole in pyloric ligated rats. "
03/01/2011 - "Rats were orally administered with pantoprazole 30 min prior to exposure to various types of ulcer inducers. "
11/01/2009 - "Pantoprazole infusion was conducted during the fasting period after endoscopy and orally for 8 weeks to encourage ulcer healing. "

08/01/1995 - "Pantoprazole was shown to be a highly-effective and well-tolerated treatment for acute duodenal ulcer. "
07/01/1999 - "The efficacy of the third pump inhibitor--pantoprazole--in the short-term treatment of Chinese patients with duodenal ulcer."
07/01/1996 - "Mexican Study Group of Pantoprazole++ in Duodenal Ulcer]."
02/01/1994 - "Pantoprazole-Duodenal Ulcer-Study Group."
01/01/2012 - "Different durations of pantoprazole infusion (0-4 hours, >4 hours, and >6 hours) had no significant effect on endoscopic and clinical outcome parameters in duodenal ulcer bleeders. "

11/01/2012 - "The aim of this study was to evaluate the immediate effect of IV pantoprazole in addition to the conventional GI cocktail in the relief of severe dyspeptic pain. "
12/01/2012 - "On the other hand, in the non-pantoprazole group, mean hospital stay was 7.6 days, time taken to start oral intake was 71.4 hours, and time taken to pain relief was 61.8 hours. "
12/01/2012 - "In the pantoprazole group, mean hospital stay was 7.4 days, time to start oral intake was 69.0 hours, and time to pain relief was 59.7 hours. "
11/01/2012 - "Selected patients with severe dyspeptic pain were randomized to treatment with a placebo, antacid, and antispasmodic (conventional group) or IV pantoprazole, antacid, and antispasmodic (pantoprazole group). "
11/01/2012 - "A randomized controlled trial of adding intravenous pantoprazole to conventional treatment for the immediate relief of dyspeptic pain."

04/01/2000 - "Efficacy of pantoprazole in the prevention of peptic ulcers, induced by non-steroidal anti-inflammatory drugs: a prospective, placebo-controlled, double-blind, parallel-group study."
12/01/2003 - "To compare the short-term (7-day) safety and efficacy of two triple-therapy regimens using pantoprazole with those of two dual-therapy regimens (one with pantoprazole and one without), for Helicobacter pylori eradication in patients with peptic ulcer disease. "
07/01/2012 - "Following healing of endoscopically confirmed peptic ulcer or reflux oesophagitis during 4-12 weeks' treatment with pantoprazole (40-80 mg/day), adult patients received open-label maintenance treatment with pantoprazole (40-160 mg/day) for up to 15 years in a single centre combined study (10-year initial study; 5-year extension study). "
11/01/1992 - "For further clinical trials in peptic ulcer disease a daily dose of pantoprazole 40 mg o.m. "
02/01/2009 - "Blood concentration of pantoprazole sodium is significantly high in hepatogenic peptic ulcer patients, especially those with a poor CYP2C19 metabolism."